| View |
DRP-13150_PI_01.pdf
|
DRP-13150
|
Doripenem (as monohydrate)
|
Drofepen
|
500 mg
|
Powder for Intravenous Infusion
|
Antibacterial (Carbapenem)
|
Mepromax Lifesciences Pvt. Ltd.
|
India
|
Renewal
|
23 April 2024
|
11 March 2030
|
| View |
|
DRP-9637-06
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Berazoba-4.5
|
4g/500mg
|
Powder for IV Infusion
|
-
|
Injectcare Parenterals Pvt. Ltd
|
India
|
CLIDP Conversion
|
31 December 2022
|
23 April 2026
|
| View |
|
DRP-1458-13
|
Thiamine mononitrate (Vitamin B1) + Pyridoxine hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
None
|
100 mg/ 5 mg/ 50 mcg
|
Tablet
|
Vitamin
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
31 December 2022
|
18 December 2025
|
| View |
|
DRP-5932-01
|
Clarithromycin
|
Kodacin
|
125 mg / 5 mL
|
Granules for Oral Suspension
|
Antibacterial (Macrolide)
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
31 December 2022
|
21 February 2027
|
| View |
|
DRP-7059-04
|
Etoricoxib
|
None
|
120 mg
|
Film-Coated Tablet
|
Selective COX-2 Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
31 December 2022
|
09 May 2026
|
| View |
|
DRP-7356-08
|
Cefixime (as trihydrate)
|
Hilcef 200
|
200 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Swiss Pharma Pvt. Ltd.
|
India
|
Renewal
|
07 April 2024
|
21 February 2029
|
| View |
|
DRP-8109-04
|
Ursodeoxycholic Acid
|
Urcia
|
300 mg
|
Film-Coated Tablet
|
-
|
Opsonin Pharma Limited
|
Bangladesh
|
CLIDP Conversion
|
31 December 2022
|
19 August 2026
|
| View |
|
DRP-9170-03
|
Budesonide
|
Aeoran
|
250 mcg/mL (500 mcg/2 mL)
|
Suspension for Nebulization
|
Glucocorticoid
|
Legency Remedies Pvt. Ltd.
|
India
|
CLIDP Conversion
|
31 December 2022
|
22 September 2025
|
| View |
|
DRP-10204-02
|
Ascorbic Acid + Cholecalciferol (Vitamin D3) + Zinc
|
Aitura-Cee
|
500 mg (equivalent to 562.50 mg Sodium Ascorbate)/ 400 IU/20 mg (equivalent to 54.90 mg Zinc Sulfate Monohydrate)
|
Capsule
|
Vitamins/Mineral
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
31 December 2022
|
06 August 2026
|
| View |
|
DRP-10602-01
|
Ampicillin (as sodium) + Sulbactam (as sodium)
|
Ampihil 1.5
|
1 g/ 500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Penicillin and Beta-Lactamase Inhibitor)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
31 December 2022
|
22 October 2026
|
| View |
|
DRP-10603-01
|
Ampicillin (as sodium) + Sulbactam (as sodium)
|
Ampihil 750
|
500 mg /250 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Penicillin and Beta-Lactamase Inhibitor)
|
Reyoung Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
31 December 2022
|
22 October 2026
|
| View |
|
DRP-10604-01
|
Levodropropizine
|
Repicof
|
30 mg/5 mL
|
Syrup
|
Cough Suppressant
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
31 December 2022
|
22 October 2026
|
| View |
|
DRP-10631-07
|
Vancomycin (as hydrochloride)
|
None
|
1 g
|
Powder for Injection (IV)
|
Antibacterial (Glycopeptide)
|
Venus Remedies Limited
|
India
|
CLIDP Conversion
|
31 December 2022
|
10 November 2026
|
| View |
|
DRP-10863-01
|
Ketorolac Trometamol
|
Ketox
|
30 mg/mL
|
Solution for Injection (IM/IV)
|
-
|
PT. Phapros Tbk
|
Indonesia
|
CLIDP Conversion
|
31 December 2022
|
19 January 2027
|
| View |
|
DRP-11851-02
|
Montelukast (as sodium) + Levocetirizine Hydrochloride
|
Monterich Plus
|
10 mg/5 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist/ Antihistamine
|
Cooper Pharma Limited
|
India
|
CLIDP Conversion
|
31 December 2022
|
10 May 2027
|
| View |
|
DRP-12932-01
|
Omeprazole
|
Omeprastar-20
|
20 mg
|
Delayed-Release Capsule
|
Proton Pump Inhibitor
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
31 December 2022
|
04 November 2027
|
| View |
|
DRP-10630-06
|
Vancomycin (as hydrochloride)
|
Vancoblis 500
|
500 mg
|
Powder for Injection (IV)
|
Antibactertial (Glycopeptide)
|
Venus `Remedies Limited
|
India
|
CLIDP Conversion
|
31 December 2022
|
10 November 2026
|
| View |
|
DRP-4616-04
|
Co-Amoxiclav
|
Wesclav
|
125 mg/ 31.25 mg per 5 mL
|
Powder for Suspension
|
Antibacterial (Penicillin - Beta-Lactamase Inhibitor Combination)
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
30 December 2022
|
28 October 2025
|
| View |
|
DRP-4961-21
|
Cefixime (as trihydrate)
|
Eriexef
|
100 mg/5 mL
|
Powder for Suspension
|
Antibacterial (Cephalosporin)
|
Sakar Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
30 December 2022
|
27 November 2028
|
| View |
|
DRP-5924-01
|
Clarithromycin
|
Kodacin
|
250 mg per 5 mL
|
Granules for Suspension
|
Antibacterial
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
30 December 2022
|
05 January 2025
|